Clinical Trials Browser

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Clinical Trials

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

EVICTION-2

EPRAD

CTC-CEC-ADN

PACPAC-EPOC

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

ODORAJA

Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1

A Study of AK112 for Advanced Solid Tumors

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC

A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

A Study of CS1002 in Subjects with Advanced Solid Tumors

New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

RACIN

Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

Study of HL-085 in Patients With Advanced Solid Tumor Tumors

Circulating Tumor Cells in Solid Tumors

FCN-437c

Phase 1a Study to Evaluate Immunogenicity of ASV®

Food Effect Study of ModraDoc006 in Combination With Ritonavir

QdV-ONCOREA

GATTO

EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)

K-BASKET, TAS-117, PI3K/AKT Gene Aberration

RET-HE

HDAC6i

A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

RESIL